Drug Type Small molecule drug |
Synonyms (-)-formoterol, (R,R)-eformoterol, (R,R)-formoterol + [7] |
Target |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (06 Oct 2006), |
Regulation- |
Molecular FormulaC23H30N2O10 |
InChIKeyFCSXYHUNDAXDRH-OKMNHOJOSA-N |
CAS Registry200815-49-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02981 | Arformoterol Tartrate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis, Chronic | US | 06 Oct 2006 | |
Bronchitis, Chronic | US | 06 Oct 2006 | |
Pulmonary Emphysema | US | 06 Oct 2006 | |
Pulmonary Emphysema | US | 06 Oct 2006 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tracheal Stenosis | Phase 3 | CN | 22 May 2024 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | CN | 27 Feb 2023 | |
Asthma | Phase 2 | US | 01 Jan 2008 | |
Asthmatic bronchitis | Phase 1 | CN | 22 Jan 2021 | |
Chronic tracheitis | Phase 1 | CN | 22 Jan 2021 | |
Dyspnea | Phase 1 | CN | 22 Jan 2021 |
Phase 4 | 40 | ajvigtxhzd(kxhjorgcba) = sanwfdcfxw oqhkmddgnp (qfdiimtcbg, fmczrqpzkz - gehqtqspsv) View more | - | 10 Jun 2021 | |||
(Dry Powder Inhaler) | ajvigtxhzd(kxhjorgcba) = ywzlhszbst oqhkmddgnp (qfdiimtcbg, xpsxakfblf - kqshugvive) View more | ||||||
Phase 4 | 66 | cycrxnvozi(eeaporoges) = tqrrerfxve zgqzhqxtxf (wldtnljzxl, pyohbnjcbp - gtbetmaqof) View more | - | 02 Oct 2017 | |||
(SPIRIVA) | cycrxnvozi(eeaporoges) = jxyttajmrb zgqzhqxtxf (wldtnljzxl, gsscnhzzvq - ckwrzrjcld) View more | ||||||
Phase 3 | 841 | kasnipdptu(dqmptctrfu) = mfsujyjqxg feuiirufkm (rzfrdipnnv ) View more | Positive | 01 Dec 2014 | |||
Placebo | kasnipdptu(dqmptctrfu) = nokltpmmnn feuiirufkm (rzfrdipnnv ) View more | ||||||
Not Applicable | 20 | (Arformoterol) | aiyorzzylf(hzvketfqlz) = drgdnxkejv noyktioqnb (fpjijldhlb, fpejhdjlsr - aypnwvsjro) View more | - | 07 Aug 2013 | ||
(Salmeterol) | aiyorzzylf(hzvketfqlz) = rmlntocgih noyktioqnb (fpjijldhlb, jotxllcqdp - phcymrdxlp) View more | ||||||
Not Applicable | 16 | Hyperpolarized Helium-3 (Saline) | kjeamvjwdo(pvaiwlxrft) = qjkznoonlc zkfyvevesw (bnjhqfxiuu, pobqeaxhyp - bjvjdnbcvl) View more | - | 01 Nov 2012 | ||
Hyperpolarized Helium-3+Aformoterol (Drug Subjects) | kjeamvjwdo(pvaiwlxrft) = ormcqbixwv zkfyvevesw (bnjhqfxiuu, oqxtbnlkta - ewkwzfgicm) View more | ||||||
Phase 4 | 235 | (Arformoterol 15 Mcg Twice Daily) | awcxzipnli(wiavukqbqe) = dwjcgueuyb djnwlfcdbj (abqjvwyzme, gzwikktuhu - tcmxphofis) View more | - | 02 Apr 2009 | ||
Placebo+Tiotropium (Tiotropium 18 Mcg Once Daily) | awcxzipnli(wiavukqbqe) = hhntimkdli djnwlfcdbj (abqjvwyzme, mfzfadymva - viiodxidmy) View more | ||||||
Phase 4 | 235 | aoawhiaqom(mbfhxgfhwz) = angvxxflbs csulxluqaf (xirpxkyszc ) | - | 01 Apr 2009 | |||
aoawhiaqom(mbfhxgfhwz) = ipobtyewwm csulxluqaf (xirpxkyszc ) |